Track Merit Medical Systems, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Merit Medical Systems, Inc. MMSI Open Merit Medical Systems, Inc. in new tab

63.64 USD
P/E
26.45
EPS
2.32
P/B
2.25
ROE
9.12
Beta
0.58
Target Price
90.64 USD
Merit Medical Systems, Inc. logo

Merit Medical Systems, Inc.

🧾 Earnings Recap – Q1 2026

Shares dropped 9% following Merit Medical’s Q1 report, reflecting investor disappointment with the cautious outlook and updated guidance despite solid top-line growth and margin improvement.

  • Q1 revenue rose 7% GAAP and 5% constant currency to $381.9 million, driven by 2.7% organic growth plus acquisition contributions.
  • Non-GAAP operating margin increased 47 basis points to a record first-quarter 19.7%.
  • Non-GAAP EPS grew 9%, and free cash flow increased 26% year-over-year to $25 million.
  • Guidance was updated to incorporate View Point Medical acquisition impacts, suggesting a more cautious outlook.
  • Strategic initiatives included the commercial launch of the Resilience TTS Esophageal Stent and expansion of the oncology portfolio through the $140 million View Point Medical acquisition.
📅
Loading chart...
Key Metrics
Earnings dateJuly 29, 2026
P/E26.45
EPS2.32
Book Value27.27
Price to Book2.25
Debt/Equity50.50
% Insiders2.399%
Growth
Revenue Growth0.08%
Earnings Growth0.39%
Estimates
Forward P/E13.93
Forward EPS4.40
Target Mean Price90.64

DCF Valuation

Tweak assumptions to recompute fair value for Merit Medical Systems, Inc. (MMSI)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Merit Medical Systems, Inc. Logo Merit Medical Systems, Inc. Analysis (MMSI)

United States Health Care Official Website Stock

Is Merit Medical Systems, Inc. a good investment? Merit Medical Systems, Inc. (MMSI) is currently trading at 63.64 USD. Market analysts have a consensus price target of 90.64 USD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 26.45. This valuation is generally in line with the broader market.

Earnings Schedule: Merit Medical Systems, Inc. is expected to release its next earnings report on July 29, 2026. The market consensus estimate for Forward EPS is 4.40.

Investor FAQ

Does Merit Medical Systems, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Merit Medical Systems, Inc.?

Merit Medical Systems, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be July 29, 2026. The company currently has a trailing EPS of 2.32.

Company Profile

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally. It operates through two segments, Cardiovascular and Endoscopy. The company offers micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention products comprising angiography, drainage, delivery systems, and embolotherapy products; oncology products, such as soft tissue biopsy products and accessories; cardiac intervention products consisting of cardiac access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention products; and spine products, including vertebral augmentation, radiofrequency ablation, and bone biopsy systems. It also provides custom procedural solutions, including critical care products, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company offers gastroenterology products, such as esophageal stents, cryoballoon and inflation devices, gauges, and balloon dilators; pulmonary products consisting of laser-cut tracheobronchial stents, and over-the-wire and direct visualization delivery systems; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals, alternate site-based physicians, technicians, and nurses through direct sales force, independent distributors, original equipment manufacturer partners, and custom procedure tray manufacturers. The company exports its products to Canada, Western Europe, Australia, Brazil, Malaysia, South Korea, the United Arab Emirates, India, New Zealand, and South Africa. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.

Exchange Ticker
NMS (United States) MMSI

Dividends

Historical Split Corporate Actions

Split Date Split Ratio to 1
Aug. 28, 2001 1.250000
April 12, 2002 1.250000
Aug. 15, 2003 1.330000
Dec. 3, 2003 1.330000
May 6, 2011 1.250000
Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion